Medartis Holding AG

Research Medartis Holding AG (MED.SW) with Bullrun company financials, valuation charts, model signals, and historical stock context.

Key Metrics

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025CHF 269.26MCHF 8.35MCHF 9.34M75.9%0.67CHF 32.97MCHF 157.72MCHF 275.87M
FY2024CHF 224.83MCHF 3.53MCHF 20.98M79.5%0.28CHF 138.69MCHF 120.77MCHF 269.65M
FY2023CHF 212.01MCHF 619.00KCHF 1.17M79.0%0.05CHF 25.20MCHF 26.92MCHF 254.96M
FY2022CHF 182.82M-CHF 5.78M-CHF 22.72M81.8%-0.49CHF 20.61MCHF 27.49MCHF 237.78M

About Medartis Holding AG

Medartis Holding AG, a medical device company, engages in the development, manufacturing, and sales of implant solutions worldwide. The company's medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery.

Related stock research

Other Healthcare stocks

Frequently asked questions

What does Medartis Holding AG do?

Medartis Holding AG, a medical device company, engages in the development, manufacturing, and sales of implant solutions worldwide. The company's medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. It provides products for the hand, wrist, forearm, elbow, shoulder, and foot and ankle, as well as for upper and lower extremities, mandible, midface, orthognathic under the APTUS and MODUS names, as well as CMX services through web portal, and kerimedical products.